BR100 Decreased By (-0.29%)
BR30 Increased By (0%)
KSE100 Decreased By (-0.3%)
KSE30 Decreased By (-0.39%)
AGHA 7.75 Decreased By ▼ -0.06 (-0.77%)
BECO 5.17 Decreased By ▼ -0.04 (-0.77%)
BML 57.55 Increased By ▲ 0.05 (0.09%)
BOP 34.40 Increased By ▲ 0.37 (1.09%)
CNERGY 10.01 Increased By ▲ 0.05 (0.5%)
CSIL 5.33 Increased By ▲ 0.02 (0.38%)
FCCL 54.60 Decreased By ▼ -0.10 (-0.18%)
FFL 16.61 Decreased By ▼ -0.08 (-0.48%)
FNEL 1.25 Increased By ▲ 0.02 (1.63%)
KEL 7.34 Decreased By ▼ -0.06 (-0.81%)
KOSM 5.78 Increased By ▲ 0.01 (0.17%)
LOTCHEM 29.35 Increased By ▲ 0.03 (0.1%)
MLCF 94.00 Decreased By ▼ -0.36 (-0.38%)
NBP 202.48 Decreased By ▼ -0.57 (-0.28%)
NCPL 57.25 Increased By ▲ 0.25 (0.44%)
NPL 67.85 Increased By ▲ 0.15 (0.22%)
OGDC 316.50 Increased By ▲ 0.66 (0.21%)
PACE 10.60 Decreased By ▼ -0.04 (-0.38%)
PAEL 42.92 Decreased By ▼ -0.28 (-0.65%)
PIBTL 16.65 Decreased By ▼ -0.09 (-0.54%)
PPL 219.29 Decreased By ▼ -0.49 (-0.22%)
PRL 50.30 Increased By ▲ 1.11 (2.26%)
PTC 70.50 Decreased By ▼ -0.03 (-0.04%)
SSGC 27.75 Decreased By ▼ -0.50 (-1.77%)
TBL 9.75 Decreased By ▼ -0.11 (-1.12%)
TELE 8.75 Decreased By ▼ -0.04 (-0.46%)
TPL 18.61 Increased By ▲ 0.37 (2.03%)
TPLP 13.62 Increased By ▲ 0.35 (2.64%)
TREET 22.65 Decreased By ▼ -0.07 (-0.31%)
TRG 60.00 Decreased By ▼ -0.14 (-0.23%)
By

RIYADH: Saudi King Salman will undergo medical tests on Sunday evening for lung inflammation, the state news agency said, citing a statement from the royal court.

The brief statement did not reveal more details. The 88-year-old king of the world’s biggest oil exporter, a major US ally in the Middle East, also received medical care for lung inflammation in May.

Salman last chaired a cabinet meeting in August, less than two weeks after a royal decree issued by him allowed the cabinet to convene in the absence of the king, crown prince or both.

The decree said that in their absence it would be chaired by the eldest member of the cabinet who is a descendant of Salman’s father King Abdulaziz Al Saud, founder of the Saudi state.

Comments

Comments are closed for this article.